Keywords: United States; allografts; blood grouping and crossmatching; cold ischemia; control groups; delayed graft function; donor exchange; follow-up studies; graft survival; humans; isoantibodies; kidney transplantation; living donors; nephrology; registries; renal dialysis; risk factors; vulnerable populations.